We are pleased to announce the upcoming international conference “Digitalization and Infectious Diseases: Improving patient outcome in the age of big data” on January 20th – January 21st, 2020 at the Conference Congress Center in Basel, Switzerland.
Without doubt, digitalization and machine learning will soon have a profound impact on the daily workflow of modern hospitals. In particular, the diagnostic process and the management of infectious diseases will be significantly improved due to data-driven approaches allowing the usage of digital biomarkers, complex medical decision support systems, and personalized advice based on big data and sophisticated algorithms.
We cordially invite you to join us for stimulating and rigorous scientific discussion. This conference will enhance your insights of digitalization, machine learning and personalized health in infectious diseases. Most recent breakthroughs and translation into applications to clinics will be shown and discussed. Join the key opinion leaders in these fields and build your network with experts in information technology, machine learning and big data, clinical microbiology, infectious diseases, biomedical research, law and ethics, and more. We look forward to seeing you at our conference.
FAMH points available (5 points per day)
FPH points available (Klinische Pharmazie & Spitalpharmazie, 50 points per day)
CME credits available (European Accreditation Council for Continuing Medical Education, 6 points per day)
View our full program.
Netherlands
Title: Rapid, reproducible resistance analysis for all- the AMR package for R
Session VIII: Next steps for technology translation into application: Clinic and Early Career perspective, Tuesday 21 January
Switzerland
Title: Ontologies fit for machine learning
Session II: Data requirements and infrastructure, Monday 20 January
Switzerland
Title: Machine learning in medicine: Early recognition of sepsis
Session I: Introduction to digitalization, Monday 20 January
Switzerland
Title: Next steps for nationwide data networks
Session II: Data requirements and infrastructure, Monday 20 January
Switzerland
Title: Challenges in developing, validating and implementing clinical decision support algorithms
Session VI: Pediatric infectious diseases, Tuesday 21 January
Switzerland
Title: Ethical and legal challenges of artificial intelligence and big data
Session VII: Social, legal, ethical and quality, Tuesday 21 January
Switzerland
Title: Combing targeted sequencing and machine learning to optimize antibiotic therapy in tuberculosis patients
Session VIII: Next steps for technology translation into application: Clinic and Early Career perspective, Tuesday 21 January
Switzerland
Title: Diagnostics next steps for infectious diseases
Session V: Clinical focus of machine learning, Monday 20 January
United Kingdom
Title: How does digitalization affect the management of infectious diseases
Session IX: Next step for technology translation into application: Non-profit and research perspective, Tuesday 21 January
Switzerland
Title: Social impact and risk governance of machine learning in the context of infectious disease
Session VII: Social, legal, ethical and quality, Tuesday 21 January
Spain
Title: Artificial intelligence to improve empiric antibiotic treatment
Session IV: Clinical applications with use cases, Monday 20 January
Switzerland
Title: What is a good control group? How to use public data?
Session III: Technology and clinics, Monday 20 January
Switzerland
Title: Data security in digitalization and machine learning
Session VII: Social, legal, ethical and quality, Tuesday 21 January
Germany
Title: Medical Devices: Regulatory requirements — a jump start
Session VII: Social, legal, ethical and quality, Tuesday 21 January
Switzerland
Title: Implementation of digital solutions in low and middle income countries.
Session IX: Next step for technology translation into application: Non-profit and research perspective, Tuesday 21 January
Switzerland
Title: Digital tools for diagnosis of infections in low-income settings
Session VI: Pediatric infectious diseases, Tuesday 21 January
United States of America
Title: Sharing is caring: Moving toward a global database for critical care
Session III: Technology and clinics, Monday 20 January
Switzerland
Title: Deep learning reveals patterns of specificity in adaptive immunity
Session VI: Pediatric infectious diseases, Tuesday 21 January
Switzerland
Title: Machine learning to parameterise individual-based models of malaria transmission
Session VIII: Next steps for technology translation into application: Clinic and Early Career perspective, Tuesday 21 January
Switzerland
Title: Personalized and public health with machine learning
Session IV: Clinical applications with use cases, Monday 20 January
Switzerland
Title: Digitalization and machine learning in clinical microbiology
Session I: Introduction to digitalization, Monday 20 January
United States of America
Title: Machine learning in sepsis: Lessons learned for digitalization and infectious disease
Session III: Technology and clinics, Monday 20 January
United States of America
Title: Incorporating AI into clinical practice: Opportunities and challenges
Session VIII: Next steps for technology translation into application: Clinic and Early Career perspective, Tuesday 21 January
Germany
Title: Challenges and risks of digitalization and machine learning in the clinics
Session V: Clinical focus of machine learning, Monday 20 January
Switzerland
Title: Machine Learning: the new way of personalized medicine
Session I: Introduction to digitalization, Monday 20 January
United States of America
Title: White-box machine learning insights into antibiotic efficacy
Session VIII: Next steps for technology translation into application: Clinic and Early Career perspective, Tuesday 21 January
An international scientific committee, we represent some of the most exciting research being done in digitalization and infectious diseases.
Frontiers in Cellular and Infection Microbiology announces its call for papers to cover the theme Digitalization and Infectious Diseases. To be covered in a special issue Research Topic in the section Clinical Microbiology they solicit your Reviews, Mini Reviews, Original Research papers and Brief Research Reports until 16 March 2020 for Abstracts and 14 July 2020 for manuscripts.
Images below – All rights reserved ©Personalized Health Basel
Basel, located in Switzerland at the heart of Europe, is a congress city with conveniently situated facilities. The Congress Center Basel enjoys a downtown location, situated directly adjacent to Basel Exhibition Centre. Travel times are short, and the historic old town, the shopping areas and the many museums and parks can be reached comfortably on foot or in a few minutes by public transport.
Public Transport | Travel by Railway |
Travel by car | Travel by plane
(pdf | 0.69 MB)
(pdf | 0.58 MB)
Congress Center Basel
Messeplatz 21
4058 Basel, Switzerland
Do you have questions regarding logistics, sponsorship or scientific content of the conference?
Copyright © Universitätsspital Basel 2020
Instagram
digital_id2020
Twitter
@Digital_id2020
@Digital_id2020